For Emerson's ASCO valve products, should we invest more in developing new features or in expanding global distribution channels to reach more customers?

Introduction

For Emerson's ASCO valve products, we're facing a critical trade-off between investing in new feature development or expanding our global distribution channels. This decision will significantly impact our product strategy, market reach, and overall business growth. I'll analyze this trade-off by examining our current product offerings, market position, and growth opportunities, then propose a data-driven approach to make an informed decision.

Step 1

Clarifying Questions (3 minutes)

• Based on our current market position, I'm thinking we might be facing increased competition. Could you provide insights into our market share trends over the past 2-3 years?

Why it matters: Helps determine if we need to focus on differentiation or market expansion Expected answer: Stable or slightly declining market share Impact on approach: Would lean towards new feature development if declining

• Considering our revenue model, I assume ASCO valves contribute significantly to our bottom line. What percentage of Emerson's overall revenue comes from ASCO valve products?

Why it matters: Indicates the strategic importance of this product line Expected answer: 15-25% of total revenue Impact on approach: Higher percentage would justify more aggressive investment

• Looking at user segments, I'm curious about the geographic distribution of our current customer base. What regions show the highest growth potential for ASCO valves?

Why it matters: Helps prioritize regions for potential distribution expansion Expected answer: Emerging markets in Asia and South America Impact on approach: Strong growth potential would favor distribution channel expansion

• Regarding technical feasibility, what's our current product development pipeline like? Are there any groundbreaking features already in progress?

Why it matters: Assesses our capacity for innovation and new feature development Expected answer: A few promising features in early stages Impact on approach: Robust pipeline might suggest focusing on bringing these to market

• Considering resource allocation, what's our current split between R&D and sales/distribution investments for ASCO valves?

Why it matters: Indicates where we might have room for increased investment Expected answer: 60% R&D, 40% sales/distribution Impact on approach: Significant imbalance might suggest reallocation of resources